Ignite Creation Date:
2024-05-05 @ 12:00 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00207662
Status:
COMPLETED
Last Update Posted:
2010-04-27
First Post:
2005-09-13
Brief Title:
A Safety and Efficacy Study of Infliximab Remicade in Patients With Moderate to Severe Active Crohns Disease
Sponsor:
Centocor Inc
Organization:
Centocor Inc
Organization Data
Organization:
Centocor Inc
Class:
INDUSTRY
Study ID:
CR004771
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Centocor Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None